<DOC>
	<DOCNO>NCT02115100</DOCNO>
	<brief_summary>Prospective , randomize , control , multicenter , international clinical trial . The study population consist patient paroxysmal persistent atrial fibrillation range hypertension sign sympathetic overdrive . Patient randomize one follow two group . group 1 : patient undergo pulmonary vein isolation , group 2 : Patients undergo pulmonary vein isolation renal artery denervation .</brief_summary>
	<brief_title>Treatment Atrial Fibrillation Patients Pulmonary Vein Isolation Combination With Renal Denervation Pulmonary Vein Isolation Only</brief_title>
	<detailed_description>The target group patient subject age &lt; 65 year , paroxysmal persistent atrial fibrillation , range hypertension ( systolic &gt; 140 mmHg &gt; 130/80 mmHg diabetic patient chronic renal disease ) sign sympathetic overdrive . Patients use least 2 anti-hypertensive 's intolerant antihypertensive medication . Atrial fibrillation terminology : If atrial fibrillation recurs terminate spontaneously within seven day , term paroxysmal AF use . This also use episode less 48 hour duration terminate electrical pharmacological cardioversion . Persistent AF define recurrent AF sustain seven day . A patient electrically pharmacologically cardioverted two day also diagnose persistent AF . After exclusion apparent secondary cause hypertension , patient randomize one follow interventional treatment : First arm : PVI ( 69 patient ) Second arm : PVI + RDN ( 69 patient ) The patient treat conscious sedation general anesthesia . The control group consist patient undergo PVI alone . The study randomize , control trial . The follow period one year interventional therapy . Patients treat clinically regular follow-up outpatient clinic hospital treat . If patient receive continuous loop recorder cardiac rhythm monitoring , data use study . The patient undergo Holter ECG monitor regular interval follow-up ( 3 , 6 12 month interventional treatment ) . During follow-up , first 3 month interventional treatment blank period , common ablative therapy AF ( ablation point need heal , paroxysms AF period associate therapy failure ) .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . The patient willing able comply protocol provide write informed consent . 2 . The patient fall within target group resistant hypertension sympathetic overdrive 3 . Patient acceptable candidate renal denervation treatment 4 . Patient &lt; 65 year age 1 . Documented leave atrial diameter trans thoracic echocardiography ( PLAX &gt; 4.5 cm ) . 2 . Contraindication chronic anticoagulation therapy heparin . 3 . Previous leave heart ablation procedure AF ( atrial fibrillation ) . 4 . Acute coronary syndrome , cardiac surgery , PCI ( percutaneous coronary intervention ) stroke within 3 month prior enrollment . 5 . Untreated hypothyroidism hyperthyroidism . 6 . More grade 1/3 valvular regurgitation and/or significant valve stenosis ( modest severe ) . 7 . LVEF ( Left ventricular function ) &lt; 45 % and/or grade 3/4 diastolic dysfunction . 8 . Enrollment another investigational drug device study . 9 . Woman currently pregnant breastfeed use reliable contraceptive measure fertile age . 10 . Mental physical inability participate study . 11 . Planned cardiovascular intervention . 12 . Life expectancy ≤ 12 month . 13 . Renal artery stenosis &gt; 50 % arterial lumen , renal artery lumen ≤3 mm . 14 . Dual triple ipsilateral renal artery ostia . 15 . Obvious secondary cause hypertension .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Paroxysmal atrial fibrillation</keyword>
	<keyword>Persistent atrial fibrillation</keyword>
	<keyword>Out range hypertension</keyword>
	<keyword>Signs sympathetic overdrive</keyword>
</DOC>